Stockscreener 앱 받기
63.99
0.05%
-0.03
Hologic Inc 주식(HOLX)의 최신 뉴스
What analysts say about Hologic Inc. stockExplosive market performance - PrintWeekIndia
What drives Hologic Inc. stock pricePhenomenal investment performance - Autocar Professional
Is Hologic, Inc. (NASDAQ:HOLX) Trading At A 38% Discount? - simplywall.st
Hologic Inc. Stock Analysis and ForecastStrongest growth potential - Jammu Links News
Is Hologic Inc. a good long term investmentExplosive trading growth - Jammu Links News
Unexpected Trends Reshaping the Uterine Fibroid (UF) Treatment - openPR.com
Sentinel Node Biopsy Market Future Business Opportunities - openPR.com
Hologic Refinances Loan to Enhance Financial Flexibility - TipRanks
Hologic’s SWOT analysis: breast health recovery boosts stock outlook - Investing.com
What to Expect From Hologic's Q3 2025 Earnings Report - MSN
Cervical Dysplasia Market is Booming Worldwide |Hologic,Qiagen,Advaxis - openPR.com
Mizuho Raises Hologic Price Target to $70, Maintains Outperform Rating - AInvest
Hologic, Inc. (HOLX) Stock Forecasts - Yahoo Finance
Hologic (HOLX) Maintains Outperform Rating, Price Target Raised by Mizuho | HOLX Stock News - GuruFocus
Hologic Rides on AI-Powered Breast Health Innovations: What's Next? - Nasdaq
How the Computer Aided Detection Market Will Evolve by 2032 - openPR.com
Why Hologic (HOLX) Dipped More Than Broader Market Today - Yahoo Finance
Hologic, Inc. Fiscal Q3 2025 Earnings Release and ProjectionsNews and Statistics - IndexBox
Hologic's Q3 2025 Earnings: A Hidden Gem in Medtech Undervaluation - AInvest
Hologic Q3 2025 Earnings Report: Analyst Expectations and Stock Performance - AInvest
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
What makes Hologic Inc. stock price move sharplyDaily Top Gainers - beatles.ru
Hologic Maintains Strength in Diagnostics but Cuts to Medicaid Could Pressure Volume - Morningstar
Global Uterine Fibroids Treatment Devices Market to grow at - openPR.com
Hips & Knees Reconstructive Market Attracts 3D Implant - openPR.com
Hologic's GYN Surgical Dominance: What's Powering The Road Ahead? - Barchart.com
Hologic's GYN Surgical Dominance: What's Powering the Road Ahead? - The Globe and Mail
Hologic (HOLX) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
Citi upgrades Hologic stock rating to Buy on valuation and growth outlook - Investing.com Nigeria
Citigroup Upgrades Hologic (HOLX) with Revised Price Target | HO - GuruFocus
Citi upgrades Hologic stock rating to Buy on valuation and growth outlook By Investing.com - Investing.com South Africa
Hologic (HOLX) Upgraded by Citi with Increased Price Target | HOLX Stock News - GuruFocus
Citigroup Upgrades Hologic to Buy From Neutral, Adjusts Price Target to $80 From $60 - MarketScreener
Hologic (HOLX) Price Target Raised by Evercore ISI Group | HOLX Stock News - GuruFocus
Is Hologic Stock's Low Valuation an Opportunity or a Value Trap? - Nasdaq
The Price Is Right For Hologic, Inc. (NASDAQ:HOLX) - 富途牛牛
BioZorb Lawsuit LawyerBreast Biopsy Marker RecallJuly 2025 Update - Levin Papantonio
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know - MSN
BioZorb Lawsuit and Settlement Information: July 2025 - AboutLawsuits.com
Hologic to Announce Financial Results for the Third Quarter of F - GuruFocus
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025 - MarketScreener
Hologic Faces Molecular Drag, But Here's Why It's Not a Major Concern - Yahoo
Hologic, Inc.(NasdaqGS: HOLX) dropped from Russell 1000 Dynamic Index - MarketScreener
How Hologic Leverages Its Financial Firepower to Drive Long-Term Value - Zacks Investment Research
Is Hologic, Inc. (NASDAQ:HOLX) Undervalued Despite Strong Growth Prospects? - AInvest
How Is Hologic’s Stock Performance Compared to Other Health Care Equipment Stocks? - Yahoo Finance
Hologic Joins NEST Governance Committee - Medical Product Outsourcing
From Now to 2032: Unpacking the Bone Mineral Densitometry - openPR.com
Global C-Arms Market Trends & Forecast 2025-2032 | Major - openPR.com
0.43%
자본화:
|
볼륨(24시간):